Atypical CF and CF related diseases

被引:28
作者
Kerem, Eitan [1 ]
机构
[1] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Cyst Fibrosis Ctr, IL-91120 Jerusalem, Israel
关键词
cystic fibrosis; atypical disease; normal sweat tests; pancreatic sufficiency; genotyping; nasal potential mesurement;
D O I
10.1016/j.prrv.2006.04.219
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The clinical characteristics of atypical CF are: symptoms that may start in infancy but the disease become clinically significant only after 10 years of age, survival into adulthood, chronic sinopulmonary disease, pancreatic sufficiency, and sweat chloride <60 meq/L. Other patients may present with single organ involvement such as CBAVD, biliary cirrhosis and portal hypertension, chronic or recurrent pancreatitis, giant nasal polyposis or hypochloremic alkalosis. It is recommended to refer such patients for CFTR genotyping, however, absence of known common mutation does not rule out CFTR associated disease, since mutations causing atypical CF are rare and whole genome scan is required for their identification. Nasal PD measurements may be helpful to establish the diagnosis of these patients; however, measurements might be also atypical. Several explanations have been suggested to explain the atypical CF disease. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:S144 / S146
页数:3
相关论文
共 10 条
[1]   MILD CYSTIC-FIBROSIS AND NORMAL OR BORDERLINE SWEAT TEST IN PATIENTS WITH THE 3849+10 KB C-]T MUTATION [J].
AUGARTEN, A ;
KEREM, BS ;
YAHAV, Y ;
NOIMAN, S ;
RIVLIN, Y ;
TAL, A ;
BLAU, H ;
BENTUR, L ;
SZEINBERG, A ;
KEREM, E ;
GAZIT, E .
LANCET, 1993, 342 (8862) :25-26
[2]  
CASALS T, 1995, HUM GENET, V95, P205
[3]   MUTATIONS IN THE CYSTIC-FIBROSIS GENE IN PATIENTS WITH CONGENITAL ABSENCE OF THE VAS-DEFERENS [J].
CHILLON, M ;
CASALS, T ;
MERCIER, B ;
BASSAS, L ;
LISSENS, W ;
SILBER, S ;
ROMEY, MC ;
RUIZROMERO, J ;
VERLINGUE, C ;
CLAUSTRES, M ;
NUNES, V ;
FEREC, C ;
ESTIVILL, X .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (22) :1475-1480
[4]  
DORK T, 1991, HUM GENET, V87, P441
[5]   CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR AND OBSTRUCTIVE AZOOSPERMIA [J].
JARVI, K ;
ZIELENSKI, J ;
WILSCHANSKI, M ;
DURIE, P ;
BUCKSPAN, M ;
TULLIS, E ;
MARKIEWICZ, D ;
TSUI, LC .
LANCET, 1995, 345 (8964) :1578-1578
[6]   A MUTATION IN CFTR PRODUCES DIFFERENT PHENOTYPES DEPENDING ON CHROMOSOMAL BACKGROUND [J].
KIESEWETTER, S ;
MACEK, M ;
DAVIS, C ;
CURRISTIN, SM ;
CHU, CS ;
GRAHAM, C ;
SHRIMPTON, AE ;
CASHMAN, SM ;
TSUI, LC ;
MICKLE, J ;
AMOS, J ;
HIGHSMITH, WE ;
SHUBER, A ;
WITT, DR ;
CRYSTAL, RG ;
CUTTING, GR .
NATURE GENETICS, 1993, 5 (03) :274-278
[7]   A SPECIFIC CYSTIC-FIBROSIS MUTATION (T3381) ASSOCIATED WITH THE PHENOTYPE OF ISOLATED HYPOTONIC DEHYDRATION [J].
LEONI, GB ;
PITZALIS, S ;
PODDA, R ;
ZANDA, M ;
SILVETTI, M ;
CAOCCI, L ;
CAO, A ;
ROSATELLI, MC .
JOURNAL OF PEDIATRICS, 1995, 127 (02) :281-283
[8]  
RAVEHAREL N, 1995, AM J HUM GENET, V56, P1359
[9]  
Romano L., 1995, Paediatrie und Paedologie, V30, P1
[10]  
STEWART B, 1995, AM J RESP CRIT CARE, V151, P899